臺灣博碩士論文加值系統

過去一段時間，DNA轉錄為RNA，RNA再轉譯為蛋白質，是分子生物學的主要信條，然而有一些RNA並未攜帶編碼的胺基酸序列，這些RNA除了一些家務基因rRNA、tRNA、snRNA之外，還有一些作為調節性分子的ncRNA（non-coding RNA）。在過去的研究大多以蛋白質的觀點來檢視基因的調控，而最近很多研究報告也指出，這些ncRNA也可能以一些我們未知的機制去調控基因表現，和其他調控因子共同構成細胞內錯綜複雜的調控網絡，以至於我們必須用新的觀點來研究這類RNA，但截至目前為止，並不曉得大部分的ncRNA如何去調控基因表現。
在我們的研究當中，在人類p53的1號內含子發現一段R697序列，在這一段RNA前約一千個序列也具有啟動子活性，而R697的大量表現能使p53 RNA的表現量提昇，但並非透過調控p53啟動子活性，而R697也會調控一些p53相關基因的RNA表現量，更進一步我們發現R697在p53基因敲除的HCT116中，也會調控這些基因的RNA表現量，也就是說R697可以不必透過功能性p53來調節這些p53相關的基因，我們認為R697可能是一段調控基因表現的ncRNA。

In the past, the central dogma is DNA information copied into mRNA, then proteins synthesized using the information in mRNA. However, some RNAs called ncRNA(non-coding RNA) do not encode amino-acid sequence information. Besides the well known house-keeping genes like rRNA, tRNA, snRNA, there are increasing number of regulatory ncRNA molecules being discovered. Regulatory molecules are usually proteins but some study showed ncRNA may regulate gene expression through a number of novel mechanisms, and ncRNA can form complex regulatory framework with other regulatory molecules. However, the regulatory mechanisms of these novel ncRNA are still largely unknown. .
In my study, I discover a new RNA species R697 transcribed within human p53 intron1. This is an polyadenylated RNA of 697 bases. The maximum size of peptide encoded by this small RNA is 37 amino acids. In addition, the 1000bp sequence before R697 in genome have promoter activity. Over-expression of R697 can up-regulate p53 RNA level but not through regulating p53 promoter activity. R697 can also up-regulate the expression of some p53-targeted genes. Furthermore, R697 can up-regulate these genes in HCT116 p53 knock-out cell. This result indicates that R697 regulates these genes independent of functional p53 and suggests that R697 may be a regulatory RNA species that can regulate gene expression.

中文摘要...................................................1
英文摘要...................................................2
背景.......................................................3
材料和方法................................................13
實驗結果..................................................22
討論......................................................28
附圖......................................................34
參考文獻..................................................45
附錄......................................................54

Abrahamson JL, Lee JM, Bernstein A. (1995) Regulation of p53-mediated apoptosis and cell cycle arrest by Steel factor. MCB 15:6953-6960.

Beroud, C., Verdier, F. and Soussi, T. (1996) p53 gene mutation: software and database. Nucl. Acids Res. 24:147–150.

Brannan CI , Dees EC , Ingram RS , Tilghman SM. (1990) The product of the H19 gene may function as an RNA. Mol Cell Biol 10: 28–36

Brown CJ, Hendrich BD, Rupert JL, Lafrenière RG, Xing Y, Lawrence J, Willard HF. (1992) The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 71:527-542.

Bourdon JC, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP, Saville MK, Lane DP. (2005) p53 isoforms can regulate p53 transcriptional activity. Genes Dev. 19:2122-2137.

Brockdorff N, Ashworth A, Kay GF, Cooper P, Smith S, McCabe VM, Norris DP, Penny GD, Patel D, Rastan S. (1991) Conservation of position and exclusive expression of mouse Xist from the inactive X chromosome. Nature 351:329-331

Brown CJ, Ballabio A, Rupert JL, Lafreniere RG, Grompe M, Tonlorenzi R, Willard HF. (1991) A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature 349:38-44.

Chang C, Simmons DT, Martin MA and Mora PT. (1979) Identification and partial characterization of new antigens from simian virus 40-transformed mouse cells. J Virol 31: 463-471.

Chen W, Böcker W, Brosius J, Tiedge H. (1997) Expression of neural BC200 RNA in human tumours. J Pathol. 183:345-351.

D P Lane and S Benchimol. (1990) p53: oncogene or anti-oncogene? Genes Dev. 4: 1-8

De Leo AB, Jay G, Appella E, Dubois GC, Law LW and Old LJ. (1979) Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci USA 76: 2420-2424.

Debrand, E., Chureau, C., Arnaud, D., Avner, P. and Heard, E. (1999) Functional analysis of the DXPas34 locus, a 3' regulator of Xist expression. MCB 19: 8513-8525.

Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C. (1992) Wild-type p53 activates transcription in vitro. Nature 358:83-86

Finlay CA, Hinds PW and Levine AJ. ( 1989) The p53 protooncogene can act as a suppressor of transformation. Cell 57: 1083-1093.

Fire A, Xu S, Montgomery M, Kostas S, Driver S, Mello C. (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.

Gartel AL and Radhakrishnan SK. (2005) Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 65:3980-3985

Hirota K, Miyoshi T, Kugou K, Hoffman CS, Shibata T, Ohta K. (2008) Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding RNAs. Nature 456: 130–134.

Hollstein M, Sidransky D, Vogelstein B, Harris CC. (1991) p53 mutations in human cancers. Science 253:49-53.

Honda R, Tanaka H, Yasuda H. (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25-27.

Ito A, Lai CH, Zhao X, Saito S, Hamilton MH, Appella E, Yao TP. (2001) p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2. EMBO 20:1331-1340.

Izant JG, Weintraub H. (1984) Inhibition of thymidine kinase gene expression by anti-sense RNA: a molecular approach to genetic analysis. Cell 36:1007-1015.

Ji P, Diederichs S, Wang W, Böing S, Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, Thomas M, Berdel WE, Serve H, Müller-Tidow C. (2003) MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22:8031-8041.

Jianchi Feng, Chunming Bi, Brian S. Clark, Rina Mady, Palak Shah, and Jhumku D. Kohtz. (2006) The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev. 20:1470-1484.

Ko LJ, Prives C. (1996) p53: puzzle and paradigm. Genes Dev.10:1054-1072.

Kobet E, Zeng X, Zhu Y, Keller D, Lu H. (2000) MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins. PNAS 97:12547-12552

Kress M, May E, Cassingena R and May P. (1979) Simian Virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 serum. J. Virol. 31: 472-483.

Lane DP and Crawford LV. (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278: 261-263.

Lee JT, Davidow LS, Warshawsky D. (1999) Tsix, a gene antisense to Xist at the X-inactivation centre. Nat. Genet. 21:400-404.

Lee JT, Lu N. (1999) Targeted mutagenesis of Tsix leads to nonrandom X inactivation. Cell 99:47-57.

Levine AJ. (1997) p53, the cellular gatekeeper for growth and division. Cell 88:323-331.

Lill NL, Tevethia MJ, Eckner R, Livingston DM, Modjtahedi N. (1997) p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen. J. Virol. 71:129-137

Linzer DIH and Levine AJ. (1979) Characterization of a 54 K dalton cellular SV40 tumor antigen resent in SV40-transformed cells and in infected embryonal carcinoma cells. Cell 1: 43-52.

Lyle R, Watanabe D, te Vruchte D, Lerchner W, Smrzka OW, Wutz A, Schageman J, Hahner L, Davies C, Barlow DP. (2000) The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1. Nat. Genet. 25:19-21.

Mahmoudi S, Henriksson S, Corcoran M, Méndez-Vidal C, Wiman KG, Farnebo M. (2009) Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol Cell 33:462-471.

Mattick JS. (2004) RNA regulation: a new genetics? Nat. Rev. Genet. 5:316-323.

Melero JA, Stitt DT, Mangel WF and Carroll RB. (1979) Identification of new polypeptide species (48-55K) immunoprecipitable by antiserum to purified large T antigen and present in simian virus 40-infected and transformed cells. J. Virol. 93: 466-480.

Mise N, Goto Y, Nakajima N, Takagi N. (1999) Molecular cloning of antisense transcripts of the mouse Xist gene. Biochem Biophys Res Commun 258:537-541.

Mittnacht S. (1998) Control of pRB phosphorylation. Curr Opin Genet Dev. 8:21-27.

Momand, J., Zambetti, G.P., Olson, D.C., George, D. & Levine, A.J. The mdm2 oncogene product forms a complex with the p53 protein and inhibit p53mediated transactivation. Cell 69: 1237-1245

Moshe Oren. (1999) Regulation of the p53 Tumor Suppressor Protein. JBC 274:36031-36034.

Nesterova, T.B., Johnston, C.M., Appanah, R., Newall, A.E., Godwin, J., Alexiou, M., Brockdorff, N. (2003) Skewing X chromosome choice by modulating sense transcription across the Xist locus. Genes Dev. 17:2177-2190.

Nigg EA. (1995) Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17: 471-80

P Hinds, C Finlay, and A J Levine. (1989) Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. J. Virol. 63: 739-746.

Qi Liwang, Li Xinmin,Zhang Shougong and An Daochang. (2006) Genetic regulation by non-coding RNAs. Science in China Series C: Life Sciences 49:201-217

Raman, V., S. A. Martensen, D. Reisman, E. Evron, W. F. Odenwald, E. Jaffee, J. Marks, and S. Sukumar. (2000) Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature 405:974-978.

Roth, J., M. Dobbelstein, D. A. Freedman, T. Shenk, and A. J. Levine. (1998) Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17:554-564.

Srikantan V, Zou Z, Petrovics G, Xu L, Augustus M, Davis L, Livezey JR, Connell T, Sesterhenn IA, Yoshino K, Buzard GS, Mostofi FK, McLeod DG, Moul JW, Srivastava S. (2000) PCGEM1, a prostate - specific gene, is overexpressed in prostate cancer. PNAS 97: 12216 - 12221.

Stommel, J. M., N. D. Marchenko, G. S. Jimenez, U. M. Moll, T. J. Hope, and G. M. Wahl. (1999) A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18:1660-1672.

Su CH, Shann YJ, Hsu MT. (2009) p53 chromatin epigenetic domain organization and p53 transcription. Mol Cell Biol. 29:93-103.

Szymanski, V.A. Erdmann and J. Barciszewski. (2003) A collection of messenger RNA-like noncoding genes, which follows categorization proposed by M. NAR. 1;31(1):429-31.

Tiedge, H., Fremeau Jr., R.T., Weinstock, P.H., Arancio, O. and Brosius, J. (1991) Dendritic location of neural BC1 RNA. PNAS 88:2093-2097.

Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J. (2001) Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology. Cancer Radiother 5:109-129.

Wang XW, Yeh H, Schaeffer L, Roy R, Moncolli V, Egly J-M, Wang Z, Friedberg EC, Evans MK, Taffe BG, Bohr VA, Weeda G, Hoeijmakers JHJ, Forrester K and Harris CC. (1995) p53 modulation of TFIIH - associated nucleotide excision repair activity. Nat. Genetics 10, 188-195.

Wassenegger M. (2000) RNA-directed DNA methylation. Plant Mol Biol. 43:203-220.

Xiaoqin Fu, Lakshmi Ravindranath, Nicholas Tran, Gyorgy Petrovics, Shiv Srivastava, Nicholas Tran, Gyorgy Petrovics, Shiv Srivastava. (2006) Regulation of Apoptosis by a Prostate-Specific and Prostate Cancer-Associated Noncoding Gene, PCGEM1. DNA and Cell Biology 25:135-141